Neurotic Disorders MRCPsych II, GA Module

Download Report

Transcript Neurotic Disorders MRCPsych II, GA Module

Neurotic Disorders
MRCPsych II, GA Module
Dr. Naresh K. Buttan
M.B.B.S., D.P.H., D.P.M., D.N.B. (Psy), C.C.S.T., Sec12 (2) Approved
Consultant Psychiatrist- HTT & Glenbourne; PCH-CIC
Hon’ Fellow- PCMD, Plymouth Locality Psychiatry Lead & AT-PMS
TPD- CT, Health Education-South West
E-mail: [email protected], [email protected]
Neurotic
DisordersScene
Setting
RCPsych ILOs
 1, 2: Identify, diagnose & formulate
 3, 4, 5: Investigate, Manage & Refer
•
•
•
•
Concept- Evolution of neurosis/ anxiety
Epidemiology, C/F, Diag. Criteria, D/D
Aetiology & Management Principles
3 case studies- 4 groups, 3 minutes on each case,
correct answer- 10 points, wrong – 0
• 2 scorers, 4 major mental disorders
• MCQs- Shout 1st & 10 for right & - 5 for wrong
Neurosis/Anxiety- Concept
•
•
•
•
•
•
•
Neurosis/ Anxiety ?
Worry (N, Webster/ Oxford Dictionary)
Stress
Normal vs. abnormal
State vs. trait
Episodic vs. Pervasive
Situational vs. Generalized
Internal (Active) vs. Reactive
Anxiety (Neurotic) Disorders: Relevance
• Prevalence: General Population
Disorder
Prev. 6/12 Rates % Lifetime Rates %
Schizophrenia
Affective Dis.
0.9
5.8
1.5
8.3
D & A dis
Anxiety Dis
6.0
8.9
16.4
14.6
•
•
•
•
•
‘Symptoms- common in gen. population
High Comorbidities
May present with physical symptoms
Proper recognition for appropriate treatment
Management- combined approach
Anxiety (Neurosis)- History
•
•
•
•
•
•
Greek: 3 Humors
Dark age: spirits/ divine punishments
‘Hysteria’ – Hippocrates (15th-16th Cent.)
‘Neurosis’- William Cullen (1777)
‘Studies in Hysteria’- S. Freud (1895)
Psychoanalytical - repression, topological mind,
fixations, defense mechanisms
• WW I → ‘Emotional’ vs. ‘Physical’, ‘Conversion
Hysteria’ or ‘Phobic Neurosis’
Anxiety (Neurosis)- History…..
• ‘Emergency Reaction’- Waltor Canon (1920s)- ‘Fight
or Flight’ response via ANS
• “Conditioning’- John Watson (1930s)- traumatic
learning situations
• ‘Instrumental Conditioning’- Mowrer (1940s)‘reinforcers’ & ‘desensitization’
• Canon Bard Theory (HPA axis)
• Tranquilizers- Benzos, Antidepressants
• Imaging: Frontal cortex & B/L Caudate in OCD,
Temporal lobes- Panic →TLEs
Anxiety (Neuroses)- Present
• Early Adverse
Life
Experiences.
• Genetic
Predisposition
Bio. Vulnerabilty
Personality/
Temperament
Bio. Changes in
Brain Fn.
Anxiety symptoms
Traumas/ SLEs
D&A
Physical
Illnesses
Anxiety Disorders
GAD
Panic
Phobic
Simple/ Sp.
Natural/ Environmental
Blood/ Injury/ Injection
Animal
Other
PTSD
OCD
Compd./Gen.
Agoraphobia
Social Phobia
Case 1
• 35 YO single female, working as receptionist,
presents with 12/12 h/o of vague body aches,
headaches, wt loss, initial insomnia, worried
about anything & everything, lethargy, no
sadness, cold sweats, numbness, using alcohol as
coping.
• No past/family history of mental illness
• Personal History: Uneventful birth, early
development, schooling.
• Lost 3 sibs in RTA during her college days
Case 1….
• Parents elderly in care home
• Previous relationship ended 18/12 ago due to her
own worries & frequent arguments
• Job cuts in work place, thinks she may lose her job
despite frequent reassurances from boss
• No D&A issues, GPE- NAD, ↑sed HR
• MSE: Tense, edgy, tremors, sweaty, ‘fear of dying’, no
delusions/ hallucinations/suicidal thoughts, MMSE27/30-recall*
Case 1…
• Gp 1: Diagnoses/ differentials
• Gp 2: Aetiology
• Gp 3: Treatments
• Gp 4: Risks/prognosis
Generalised Anxiety Disorder
• Essence: generalised free floating persistent anxiety
• Epidemiology: 6/12- ECA: 2.5- 6.4%, Early onset (Av 21),
F>M, Single, Unemployed.
• Aetiology:
a) Genetic: Heritability 30%
b) Neurobiological: ANS arousal, loss of regulatory control
of cortisol (HPA axis), abnormal neurotransmitters
(↓GABA, 5HT dysregulation,)
c) Psychological: Unexpected -ve SLEs (death, loss, rape),
chronic stressors; conditioning, reinforcers, failed
repression, loss of object /attachment
Generalised Anxiety Disorder….
Diagnostic criteria: ICD 10-: Pervasive anxiety & at least 4
(min 1 from autonomic) of:
a. ANS- palpitation, sweating, trembling, dry mouth
b. Physical: SOB, choking, chest pain, nausea
c. MSE: dizziness, DPR/DR, LOC, fear of dying
d. General: hot flushes, numbness, tingling
e. Tension: muscle tension, aches/ pains, restlessness,
edgy, lump in throat, dysphagia
f. Other: startle reaction, blank mind, irritability,
insomnia
Generalised Anxiety Disorder…..
Comorbidity/ D/D:
• Other anxiety disorders
• D & A abuse & withdrawal
• Medications (CVS: AntiHT, antiarrhythmics, RS:
brochodilators,CNS:
anticholinergics,AEDs,
DA,
Psychiatric: ADs, NLs, antabuse reaction, bezo
withdrawal)
• GMCs (CVS: arrhythmias, MVP, CCF; RS: Asthma,
COPD, PE; CNS: TLE, VBI; Endocrine: Hyperthyroidism,
hypoparathyroidism, ↓sed BM, phaeochromocytoma
Misc: Anaemia, porphyria, SLE, pellagra, Carcinoid)
GAD- Treatments

Psychological: less effective than in other anxiety disorders,
CBT useful- education, cognitive remediation. BT- exposure,
relaxation, control of hyperventilation.

Physical: ECT/ Psychosurg.- rare (severe intractable)

a)
b)
c)
d)
Pharmacological: directed towards symptom domains:
Psychic- buspirone
Somatic- benzos
Depressive- TCAs, SSRIs, SNRIs, Mirtazepine, MAOIs
ANS/CVS- β blockers
Case 2
• 35 YO married unemployed male with h/o
ADS, presents with 12 yrs h/o cleaning &
checking rituals, feeling hopeless &
suicidal, homebound.
• Prev. treated with SSRIs, Antipsychotics partial response, disengaged from CBT
• N. birth/early dev/schooling, graduated,
worked as Real Estate manager till 25,
unemployed & on DLA
Case 2…
• F/H/o: Depression in mom, strict parents- high
expectations, 3 sibs-all perfectionists
• O/E:GPE- NAD, rough skin, mildly ↑sed AST/ALT
• MSE: Pressured, agitated, restless, doubts re
contamination & need to check everything, no
delusions/hallucinations, fleeting suicidality, no
plans, MMSE- couldn’t complete as had to check
frequently
Case 2
• Gp 2: Diagnoses/ diffrertials
• Gp 3: Aetiology
• Gp 4: Treatments
• Gp 1: Risks/prognosis
Obsessive Compulsive Disorders
• Essence: a common chronic condition with obsessions &/or
compulsions causing severe distress .
• Clinical features:
Obsessions
a)
b)
Recurrent,
persistent,
intrusive,
irrational
thoughts/ impulses/ images
causing severe anxiety
Person attempts to ignore/
suppress/ neutralize with
some other thoughts or
actions.
Ownership
maintained- not alienation
Compulsions
a)
b)
Repetitive behaviours/
mental acts in response to
obsession or according to
strict rules
Behaviours/ mental acts
aim at preventing/ reducing
distress or dreaded
outcomes
OCD….
• Types: Check(63%), wash(50%), contamination (45%),
doubt(42%), bodily fears (36%), count (36%), symmetry
(31%), aggressive (28%)
• Epidemiology: Age- 20yrs, F=M, Prev. – 0.5-2%
• Associations: Cluster C (40%), anankastic traits (5-15%),
Schiz. (5-45%), Sydenham chorea (70%), TS
• Comorbidity: Dep.(50-70%), D & A, Soc. phobia, panic
dis, ED, tic disorder (40% Juvenile OCD), TS
• D/D: Normal worries, anankastic PD, schizophrenia,
phobias,
depression,
hypochondriasis,
BDD,
trichotillomania.
OCD- Mx…..
A
1)
2)
3)
Psychological:
Supportive: valuable, family, groups
BT: ERP, Thought stopping (ruminations)
CBT: Not proven effective, RET
B Pharmacological:
a) SSRIs: 1st line, lag period (12 weeks), long term
b) TCAs (CMI)/ MAOIs
c) Augmentation: buspirone, antipsychotics, lithium
C Physical: ECT- suicidal, Psychosurgery- intractable (treatment
resistant- 2 Ads, 3 Combinations, ECT & BT)- streotactic
cingulotomy (65% success)
OCD- Aetiology
Theories:
1) Neurochemical: 5HT dysregulation, 5HT/DA interaction
2) Immunological: CMI (against basal ganglia peptides)
3) Imaging: CT/MRI- B/L reduction in caudate size PET/SPECThypermetabolism in orbitofrontal gyrus & BG
4) Genetic: MZ: DZ= 50-80:25%, 3-7% 1st degree relatives
5) Psychological: Defective arousal & / or inability to control
unpleasant, obsessions -conditioned stimuli, compulsionsreinforced learned behaviours
6) Psychoanalytical: regression, isolation, undoing & reaction
formation
OCD…….
•
•
Course: sudden onset, fluctuating/ chronic,
Outcome:
20-30%
significant,
40-50%
moderate, 20-40% chronic/worsening.
• Prognostic factors:
A. Poor: giving in, longer duration, early onset,
bizarre compulsions, symmetry, comorbid
depression, PDs (schizotypal),
B. Good: good premorbid social & occupational
level, a precipitating event, episodic symptoms.
Case 3
• 22 YO single PG student presents with 3/12
h/o nightmares, flashbacks, panic attacks,
fearfulness, insomnia, poor appetite, loss
of conc. & enjoyment.
• Was mugged & date raped 4/12 ago, police
arrested the culprits & she gave witness.
• N. Birth/early dev/schooling/peers/ good
grades
• CSA: by elderly neighbour 7-8 yrs age
Case 3…
• No past/ family history
• O/E: GPE- NAD, tremors & ↑sed HR
• MSE: Anxious, guarded, slow to warm up,
describes flashbacks of incidents, low self
esteem, no depressive/psychotic
symptoms/signs, willing to engage in
treatment.
Case 3…
• Gp 3: Diagnoses/ differentials
• Gp 4: Aetiology
• Gp 1: Treatment
• Gp 2: Risks/prognosis
Post Traumatic Stress Disorder (PTSD)
•
•
1.
2.
3.
4.
5.
Essence: Severe psychological disturbance following a trauma,
involuntary re-experiencing with symptoms of hyperarousal,
avoidance & emotional numbing.
Symptoms/Signs: Onset within 6/12 (ICD10) of trauma, at least
1/12 with clinically significant distress or impairment in social,
occupational or other important areas; 2 or more ‘persistent
symptoms of ↑sed psychological sensitivity & arousal:
Initial/ middle insomnia
Irritability/ anger outbursts
Poor concentration
Hypervigilance
↑sed startle response
•
•
•
•
PTSD- Aetiology
Psychological: ‘Remodeling of Underlying Schemas’requires holding of trauma experience in ‘active
memory’ (working through). Dissociation protects
from being overwhelmed.
Biological: Neurophysiological changes → permanent
neuronal changes (chronic/ persistent stress/
reliving). Neurotransmitters- NA/ 5HT/ GABA/
Endogenous opioids / glucocorticoids.
Neuroimaging: ↓sed R hippocampal vol.,
dysfunction of amygdala & associated projections↑sed fear response
Genetic: Higher concordance in MZ > DZ twins
PTSD…..
• Epidemiology: Risk of PTSD (20-30%), Median(8-13%),
Lifetime prevalence-7.8%, F: M= 2:1, Cultural
differences +
• Risk factors: Vulnerability: low education, low SE class,
Afro-Carribean /Hispanic, Female, low self esteem /
neurotic traits, past/ family h/o psychiatric problems,
previous traumas (CSA).
• Comorbidity: Depression, mood disorder, D & A,
somatisation disorders.
• D/D: ASR/ D, Enduring personality change, adjustment
dis., other anxiety dis., depression, mood disorder, OCD,
schiz., D & A.
PTSD- Management
• Psychological:
a) CBT: TOC- education, self monitoring, anxiety
management, exposure, cognitive restructuring
b) EMDR: Voluntary multisaccadic eye movements
c) Psychodynamic: meaning & work through
• Phramacological: limited evidence, for comorbid
1) Depression: SSRIs/TCAs/MAOIs
2) Anxiety: Benzo/buspirone/ ADs
3) Intrusive thoughts: CBZ, Li, Fluvoxamine
PTSD- Course & Outcome
50% recover in 1 yr, 30% chronic course
Outcome dependent on initial symptom
severity
Recovery helped by: good social support,
absence of maladaptive coping, no further
traumas, no D&A/Forensic
MCQ 1
Q1. The ‘the sense of impending doom always’
is the main feature of which of the following:
A.Mania
B.Alcohol withdrawal
C.Generalized Anxiety Disorder
D.Depression
MCQ 2.
Q 2: Obsession is:
A. False, firm unshakable belief out of social/
cultural context
B. Own, Irrational, Repetitive, Intrusive
egodystonic belief/ impulse/ image
C. Irrational fear of a specific situation/object
causing avoidance
D. Perception without an external stimulus
MCQ 3.
Q 3: The main feature of PTSD is:
A. Own, Irrational, Repetitive, Intrusive ego
dystonic belief/ impulse/ image
B. Reliving traumas with resultant arousal,
numbing and avoidance associated with
trauma
C. Perception without an external stimulus
D. Repetitive acts/thoughts to neutralize
anxiety caused by obsessions
Answers
• Q1. C
• Q 2. B
• Q 3. B
Further reading
• Oxford Textbook of Psychiatry, 5th Ed, Gelder M,
Harrison & Cowen P., Oxford University Press 2006
• ICD 10- Clinical Description & Diagnostic Guidelines,
WHO 1994
• DSM IV-TR- A Clinical Guide to Differential Diagnosis,
APA 1994, Revised 2004
• The Maudsley Prescribing Guidelines, 10th Ed, Taylor
D, Paton C & Kapur S, Informa Healthcare 2009
Thank You & Best Wishes !